Federated Hermes, Inc. Novartis Ag Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Federated Hermes, Inc. holds 94,488 shares of NVS stock, worth $9.81 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

94,488

Previous 97,936 3.52%

Holding current value

$9.81 Million

Previous $10.4 Million 4.24%

% of portfolio

0.02%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$106.13 - $120.89 $365,936 - $416,828	-3,448 Reduced 3.52%	94,488 $10.9 Million
Q2 2024 Aug 08, 2024	SELL	$92.57 - $107.37 $1.14 Million - $1.32 Million	-12,266 Reduced 11.13%	97,936 $10.4 Million
Q1 2024 May 14, 2024	SELL	$95.27 - $108.47 $938,695 - $1.07 Million	-9,853 Reduced 8.21%	110,202 $10.7 Million
Q4 2023 Jan 31, 2024	SELL	$92.27 - $101.54 $341,029 - $375,291	-3,696 Reduced 2.99%	120,055 $12.1 Million
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $278,032 - $308,556	-2,935 Reduced 2.32%	123,751 $12.6 Million
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $1.5 Million - $1.7 Million	-16,220 Reduced 11.35%	126,686 $12.8 Million
Q1 2023 May 08, 2023	BUY	$80.03 - $92.81 $511,151 - $592,777	6,387 Added 4.68%	142,906 $13.1 Million
Q4 2022 Feb 13, 2023	SELL	$75.55 - $92.52 $1.76 Million - $2.16 Million	-23,358 Reduced 14.61%	136,519 $12.4 Million
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $1.22 Million - $1.43 Million	16,398 Added 11.43%	159,877 $12.2 Million
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $1.49 Million - $1.74 Million	-18,521 Reduced 11.43%	143,479 $12.1 Million
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $5.2 Million - $5.88 Million	64,879 Added 66.8%	162,000 $14.2 Million
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $1.63 Million - $1.8 Million	-20,445 Reduced 17.39%	97,121 $8.5 Million
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $684,416 - $796,226	8,369 Added 7.66%	117,566 $9.62 Million
Q2 2021 Aug 16, 2021	BUY	$85.24 - $94.15 $1.6 Million - $1.76 Million	18,736 Added 20.71%	109,197 $9.96 Million
Q1 2021 May 13, 2021	SELL	$83.5 - $98.47 $132,932 - $156,764	-1,592 Reduced 1.73%	90,461 $7.73 Million
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $85,174 - $103,023	-1,091 Reduced 1.17%	92,053 $8.69 Million
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $231,963 - $256,984	-2,824 Reduced 2.94%	93,144 $8.1 Million
Q2 2020 Aug 13, 2020	SELL	$80.93 - $91.1 $2.2 Million - $2.48 Million	-27,206 Reduced 22.09%	95,968 $8.38 Million
Q1 2020 May 13, 2020	BUY	$70.67 - $99.01 $4.51 Million - $6.32 Million	63,830 Added 107.56%	123,174 $10.2 Million
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $179,496 - $202,947	-2,128 Reduced 3.46%	59,344 $5.62 Million
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $125,316 - $138,090	-1,465 Reduced 2.33%	61,472 $5.34 Million
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $3.22 Million - $3.96 Million	-42,688 Reduced 40.41%	62,937 $5.75 Million
Q1 2019 May 10, 2019	SELL	$75.32 - $86.15 $3.61 Million - $4.12 Million	-47,863 Reduced 31.18%	105,625 $10.2 Million
Q4 2018 Feb 13, 2019	SELL	$73.66 - $82.02 $200,870 - $223,668	-2,727 Reduced 1.75%	153,488 $11.8 Million
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $2.21 Million - $2.56 Million	33,008 Added 26.79%	156,215 $13.5 Million
Q2 2018 Aug 10, 2018	SELL	$64.91 - $73.36 $318,708 - $360,197	-4,910 Reduced 3.83%	123,207 $9.31 Million
Q1 2018 May 09, 2018	SELL	$70.39 - $84.15 $8.27 Million - $9.89 Million	-117,559 Reduced 47.85%	128,117 $10.4 Million
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $104,878 - $112,578	1,450 Added 0.59%	245,676 $0
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $18.1 Million - $18.9 Million	244,226	244,226 $21 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Novartis Ag Transaction History